Acute amphetamine response predicts antidepressant and antipsychotic responses to lithium carbonate in schizophrenic patients (Q72490643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115437%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Acute amphetamine response predicts antidepressant and antipsychotic responses to lithium carbonate in schizophrenic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115437%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

D. P. van Kammen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6115437

8 August 2023

J. P. Docherty

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6115437

8 August 2023

S. R. Marder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6115437

8 August 2023

W. E. Bunney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6115437

8 August 2023

language of work or name

English

0 references

publication date

1 June 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115437%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

27 October 2019

https://api.elsevier.com/content/article/PII:0165178181900330?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

https://api.elsevier.com/content/article/PII:0165178181900330?httpAccept=text/plain

8 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

8 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115437%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115437%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115437%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

313-325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115437%20AND%20SRC:MED&resulttype=core&format=json

Antipsychotic effects of lithium in schizophrenia

27 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Behavioral and neuroendocrine effects of low dose ET-495: Antagonism by haloperidol

8 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Dopaminergic agonist properties of ephedrine-theoretical implications

8 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline

8 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study

8 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Lithium prevention of amphetamine-induced ?manic? excitement and of reserpine-induced ?depression? in mice: Possible role of 2-phenylethylamine

8 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Methods for reliable longitudinal observation of behavior

8 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Flexible System for the Diagnosis of Schizophrenia: Report from the WHO International Pilot Study of Schizophrenia

8 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Prediction of Treatment Outcome With Lithium

8 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Urinary MHPG levels and tricyclic antidepressant drug selection. A preliminary communication on improved drug selection in clinical practice

8 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Prediction of antidepressant responses to lithium

8 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants

8 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Lithium inhibition of norepinephrine and dopamine receptors

8 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Effect of Lithium on Brain Dopamine

8 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium

8 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

The effect of chronic lithium administration on dopamine metabolism in rat striatum

8 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Evoked release of norepinephrine and serotonin from brain slices: inhibitoon by lithium

8 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Postpsychotic state, convalescent environment, and therapeutic relationship in schizophrenic outcome

8 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Schizophrenia: elevated cerebrospinal fluid norepinephrine

8 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Catecholamine Metabolism, Depressive Illness, and Drug Response

8 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Postpsychotic depression and the need for personal significance

8 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

An investigation of the postpsychotic depressive syndrome

8 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Dopamine Excretion in Affective States and following Li2CO3 Therapy

8 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Dopamine receptor binding in rat striatum: ultradian rhythm and its modification by chronic imipramine

8 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Major psychiatric disorders. A four-dimensional model.

8 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity

8 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Case history data and prognosis in schizophrenia.

8 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Phenylethylamine in paranoid chronic schizophrenia

8 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: Metoclopramide, thiethylperazine, and molindone as pharmacological tools

8 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Chronic lithium reduces [3H]spiroperidol binding in rat striatum

8 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

8 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Use of Antidepressant Drugs in Schizophrenia

8 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients

8 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

8 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Inhibition by lithium of dopamine-sensitive adenylate-cyclase in the rat brain

8 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

The dopamine hypothesis of schizophrenia revisited

8 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Lithium treatment in post-psychotic depression

8 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment

8 August 2023

51

author name string

van Kammen

publication date

1981

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients

8 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Prediction of imipramine antidepressant response by a one-day dextro- amphetamine trial

8 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

Prediction of Antidepressant Response to Lithium Carbonate by a 1-Day Administration of <i>d</i>-Amphetamine in Unipolar Depressed Women

8 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0165-1781(81)90033-0

8 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115437%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference